Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden and endotoxin risks.

Manufacturing difficulties are holding back the commercial development of heart disease cell therapies, according to researchers who say “cell free” treatment could be an easy-to-make alternative.

Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare and pharma industries.

The LineaDNA platform is a proprietary, cell-free DNA production system leveraging Applied DNA’s deep expertise in large-scale PCR. Unlike conventional plasmid-based DNA production methods, the ...

Applied DNA Sciences, Inc., a leader in synthetic DNA manufacturing powered by scalable PCR platforms, announced it received a seventh follow-on order valued at more than $600,000 for a multi-gram ...

The LineaDNA platform is a proprietary, cell-free DNA production system leveraging Applied DNA’s deep expertise in large-scale PCR. Unlike conventional plasmid-based DNA production methods, the ...

About the LineaDNA™ and LineaIVT™ Platforms The LineaDNA platform is a proprietary, cell-free DNA production system leveraging Applied DNA’s deep expertise in large-scale PCR.

Aqtual’s proprietary platform evaluates protein regulation, epigenetics, and transcriptomics solely using cell-free DNA fragments found in the blood.

News Vermont engineer revives pay phones for free calls in areas with poor cell service By Associated Press - ...